Showing results (2041-2050 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|February 10, 2021
EQ-5D-Y Value Set for SloveniaValentina Prevolnik Rupel, Marko Ogorevc,
Pharmacoeconomics|February 19, 2021
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of VisionSimone A Huygens, Matthijs M Versteegh, Stefan Vegter, et al.
Pharmacoeconomics|February 22, 2021
Utility Decrements Associated with Adult Overweight and Obesity in Australia: A Systematic Review and Meta-AnalysisJoseph Carrello, Alison Hayes, Anagha Killedar, et al.
Pharmacoeconomics|October 2, 2019
Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model DesignDaniel M Sugrue, Thomas Ward, Sukhvir Rai, et al.
Pharmacoeconomics|October 23, 2018
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSarah Davis, Rachid Rafia, Christopher Carroll, et al.
Pharmacoeconomics|December 16, 2021
Four Aspects Affecting Health Economic Decision Models and Their ValidationTalitha Feenstra, Isaac Corro-Ramos, Dominique Hamerlijnck, et al.
Pharmacoeconomics|July 27, 2019
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount HoodSeamus Kent, Frauke Becker, Talitha Feenstra, et al.
Pharmacoeconomics|March 7, 2014
A comparative analysis of two contrasting European approaches for rewarding the value added by drugs for cancer: England versus FranceMichael Drummond, Gerard de Pouvourville, Elizabeth Jones, et al.
Pharmacoeconomics|March 20, 2014
Cost-effectiveness analyses in multiple sclerosis: a review of modelling approachesShien Guo, Christopher Pelligra, Catherine Saint-Laurent Thibault, et al.
Pageof 336